Study wrapper · #715
MOTS-c preserves mitochondrial subpopulation bioenergetics and genome integrity to attenuate cardiac ischemia reperfusion injury.
Editor's note
In an isolated (Langendorff-perfused) rat heart model, researchers found that MOTS-c, given before ischaemia or at reperfusion, improved post-ischaemic mechanical recovery and partly preserved mitochondrial function after ischaemia-reperfusion injury. The design is mechanistic and ex vivo: female Wistar rat hearts, six per group, studied outside the body, so systemic and long-term effects are not captured. Effects varied across mitochondrial subpopulations and parameters, and the authors note the signalling mechanism still needs validation. These are preclinical findings; human data are needed before any clinical conclusions can be drawn. The result is consistent with a recurring MOTS-c theme, cardioprotection against ischaemic and oxidative stress in animal hearts, but replication in small isolated-organ models does not substitute for controlled human trials, of which there are none for exogenous MOTS-c.
Plain-language abstract
Heart attacks damage tissue in two waves: first from lack of blood flow, then from the flood of blood returning (called reperfusion injury). Researchers tested whether MOTS-c, a small protein made by mitochondria, could protect against this. They used rat hearts kept beating outside the body (six hearts per group), cut off blood flow for 30 minutes, then restored it for 60 minutes, giving MOTS-c either just before or at the moment flow returned. Hearts given MOTS-c recovered their pumping ability better, showed less oxidative stress, and kept more of their mitochondrial function and DNA intact. The protection appeared in both types of heart-muscle mitochondria, though the size of the benefit differed by measurement. Because this used isolated animal hearts rather than living people, it cannot tell us how MOTS-c would behave in patients, and the authors say the exact mechanism still needs confirming. It adds to a growing set of animal studies suggesting MOTS-c helps hearts cope with mitochondrial stress.